Barlaka Eleftheria, Görbe Anikó, Gáspár Renáta, Pálóczi János, Ferdinandy Péter, Lazou Antigone
Laboratory of Animal Physiology, School of Biology, Aristotle University of Thessaloniki, Greece.
Cardiovascular Research Group, Department of Biochemistry, University of Szeged, Hungary; Pharmahungary Group, Szeged, Hungary.
Pharmacol Res. 2015 May-Jun;95-96:102-10. doi: 10.1016/j.phrs.2015.03.008. Epub 2015 Mar 28.
Heart failure still remains one of the leading causes of morbidity and mortality worldwide. A major contributing factor is reactive oxygen/nitrogen species (RONS) overproduction which is associated with cardiac remodeling partly through cardiomyocyte apoptosis. Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear receptor superfamily and have been implicated in cardioprotection. However, the molecular mechanisms are largely unexplored. In this study we sought to investigate the potential beneficial effects evoked by activation of PPARβ/δ under the setting of oxidative stress induced by H2O2 in adult rat cardiac myocytes. The selective PPARβ/δ agonist GW0742 inhibited the H2O2-induced apoptosis and increased cell viability. In addition, generation of RONS was attenuated in cardiac myocytes in the presence of PPARβ/δ agonist. These effects were abolished in the presence of the PPARβ/δ antagonist indicating that the effect was through PPARβ/δ receptor activation. Treatment with PPARβ/δ agonist was also associated with attenuation of caspase-3 and PARP cleavage, upregulation of anti-apoptotic Bcl-2 and concomitant downregulation of pro-apoptotic Bax. In addition, activation of PPARβ/δ inhibited the oxidative-stress-induced MMP-2 and MMP-9 mRNA upregulation. It is concluded that PPARβ/δ activation exerts a cytoprotective effect in adult rat cardiac myocytes subjected to oxidative stress via inhibition of oxidative stress, MMP expression, and apoptosis. Our data suggest that the novel connection between PPAR signaling and MMP down-regulation in cardiac myocytes might represent a new target for the management of oxidative stress-induced cardiac dysfunction.
心力衰竭仍是全球发病和死亡的主要原因之一。一个主要促成因素是活性氧/氮物种(RONS)的过量产生,这部分通过心肌细胞凋亡与心脏重塑相关。过氧化物酶体增殖物激活受体(PPARs)是属于核受体超家族的配体激活转录因子,并且已被证明具有心脏保护作用。然而,其分子机制在很大程度上尚未被探索。在本研究中,我们试图研究在过氧化氢诱导的成年大鼠心肌细胞氧化应激情况下,激活PPARβ/δ所引发的潜在有益作用。选择性PPARβ/δ激动剂GW0742抑制了过氧化氢诱导的细胞凋亡并提高了细胞活力。此外,在存在PPARβ/δ激动剂的情况下,心肌细胞中RONS的产生减少。在存在PPARβ/δ拮抗剂的情况下,这些作用被消除,表明该作用是通过PPARβ/δ受体激活实现的。用PPARβ/δ激动剂处理还与半胱天冬酶-3和聚(ADP-核糖)聚合酶(PARP)裂解的减弱、抗凋亡蛋白Bcl-2的上调以及促凋亡蛋白Bax的同时下调有关。此外,PPARβ/δ的激活抑制了氧化应激诱导的基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)mRNA上调。结论是,PPARβ/δ激活通过抑制氧化应激、MMP表达和细胞凋亡,对遭受氧化应激的成年大鼠心肌细胞发挥细胞保护作用。我们的数据表明,心肌细胞中PPAR信号传导与MMP下调之间的新联系可能代表了治疗氧化应激诱导的心脏功能障碍的新靶点。